12 West Capital Management LP Sells 60,000 Shares of Oscar Health, Inc. $OSCR

12 West Capital Management LP trimmed its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 32.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 126,855 shares of the company’s stock after selling 60,000 shares during the period. Oscar Health comprises 0.2% of 12 West Capital Management LP’s holdings, making the stock its 18th biggest holding. 12 West Capital Management LP’s holdings in Oscar Health were worth $1,823,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Freestone Grove Partners LP bought a new stake in shares of Oscar Health during the fourth quarter worth $7,313,000. Schonfeld Strategic Advisors LLC bought a new position in Oscar Health in the 4th quarter worth about $2,282,000. Cetera Investment Advisers grew its stake in Oscar Health by 24.7% in the 4th quarter. Cetera Investment Advisers now owns 43,412 shares of the company’s stock worth $624,000 after acquiring an additional 8,592 shares in the last quarter. Equitable Holdings Inc. grew its stake in Oscar Health by 7.0% in the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock worth $186,000 after acquiring an additional 850 shares in the last quarter. Finally, Cantor Fitzgerald L. P. grew its stake in Oscar Health by 97.2% in the 4th quarter. Cantor Fitzgerald L. P. now owns 246,818 shares of the company’s stock worth $3,547,000 after acquiring an additional 121,674 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Trading Down 1.0%

NYSE:OSCR opened at $28.27 on Thursday. The firm has a 50 day moving average of $21.03 and a 200 day moving average of $16.78. The stock has a market capitalization of $8.52 billion, a price-to-earnings ratio of -47.91, a PEG ratio of 2.00 and a beta of 2.37. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $29.81. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business’s quarterly revenue was up 52.6% on a year-over-year basis. During the same quarter last year, the company posted $0.92 earnings per share. As a group, sell-side analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Janet Liang sold 12,475 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $273,701.50. Following the completion of the transaction, the insider owned 259,057 shares of the company’s stock, valued at $5,683,710.58. This trade represents a 4.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Scott Blackley sold 100,000 shares of the firm’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the transaction, the chief financial officer directly owned 1,216,660 shares of the company’s stock, valued at approximately $28,177,845.60. This trade represents a 7.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 189,660 shares of company stock valued at $4,283,140 over the last quarter. Insiders own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on OSCR. Wells Fargo & Company set a $20.00 price objective on shares of Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Weiss Ratings upgraded shares of Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 9th. Wolfe Research began coverage on shares of Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating on the stock. Zacks Research downgraded shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 5th. Finally, Robert W. Baird increased their price objective on shares of Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Three investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $20.78.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.